Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Immediate Communication
  • Published:

Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function

Molecular Psychiatry volume 5, pages 137–141 (2000)Cite this article

Abstract

Corticotropin-releasing hormone (CRH) is the principal regulator of the hypothalamic-pituitary-adrenal (HPA) axis and an activator of the sympathoadrenal (SA) and systemic sympathetic (SS) systems. Mental disorders, including major depression and, more recently, Alzheimer's disease have been associated with dysregulation of the HPA axis and the SA/SS systems. Treatment of rats or monkeys with the novel CRH receptor type 1 (CRH-R1) antagonist antalarmin inhibits the HPA and/or the SA/SS axes. This is the first study to examine the potential direct effect of antalarmin on human adrenal function. Adrenocortical and adrenomedullary cells were characterized by double-immunohistochemistry with anti-17 α hydroxylase (cortical cells) and anti-chromogranin A (chromaffin cells). Expression of CRH, ACTH, CRH type I and type II receptor mRNA were analyzed by reverse-transcription (RT) PCR. Human adrenal cortical and/or chromaffin cells in co-culture were incubated with CRH, antalarmin, and both CRH and antalarmin in vitro. Exposure of these cells to corticotropin or vehicle medium served as positive and negative controls, respectively. Cortical and chromaffin tissues were interwoven in the human adrenals, and both in situ and in the co-culture system the endocrine cell types were in close cellular contact. ACTH, CRH, and CRH-R1 and CRH-R2 mRNAs were expressed in the human adrenal as determined by RT-PCR. CRH (10−8 M) led to a moderate increase of cortisol release (145.7 ± 20.0%) from cortical and chromaffin adrenal cells in co-culture. This effect corresponded to 41.8% of the maximal increase induced by ACTH (10−8 M). The action of CRH was completely inhibited by antalarmin. CRH, ACTH, and both CRH-R1 and CRH-R2 mRNAs are expressed in the adult human adrenal gland. CRH stimulates cortisol production in cortical and chromaffin cell co-cultures. This effect is blocked by antalarmin, a selective CRH-R1 receptor antagonist, suggesting that CRH-R1 receptors are involved in an intraadrenal CRH/ACTH control system in humans.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Wong ML, Licinio J, Pasternak KI, Gold PW . Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry Endocrinology 1994; 135: 2275–2278

    Article  CAS  Google Scholar 

  2. Vale W, Spiess J, Rivier C, Rivier J . Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin Science 1981; 213: 1394–1397

    Article  CAS  Google Scholar 

  3. Vita N, Laurent P, Lefort S, Chalon P, Lelias JM, Kaghad M et al. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors FEBS Lett 1993; 335: 1–5

    Article  CAS  Google Scholar 

  4. Liaw CW, Lovenberg TW, Barry G, Oltersdorf T, Grigoriadis DE, de Souza EB . Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid Endocrinology 1996; 137: 72–77

    Article  CAS  Google Scholar 

  5. Andreis PG, Neri G, Belloni AS, Mazzocchi G, Kasprzak A, Nussdorfer GG . Interleukin-1 beta enhances corticosterone secretion by acting directly on the rat adrenal gland Endocrinology 1991; 129: 53–57

    Article  CAS  Google Scholar 

  6. Smith R, Mesiano S, Chan EC, Brown S, Jaffe RB . Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cells J Clin Endocrinol Metab 1998; 83: 2916–2920

    CAS  PubMed  Google Scholar 

  7. Chakravorty A, Mesiano S, Jaffe RB . Corticotropin-releasing hormone stimulates P450 17alpha-hydroxylase/17,20-lyase in human fetal adrenal cells via protein kinase C J. Clin Endocrinol Metab 1999; 84: 3732–3738

    CAS  PubMed  Google Scholar 

  8. Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ, Swaab DF . Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression Am J Psychiatry 1995; 152: 1372–1376

    Article  CAS  Google Scholar 

  9. Luger A, Deuster PA, Kyle SB, Gallucci WT, Montgomery LC, Gold PW et al. Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptions to physical training N Engl J Med 1987; 316: 1309–1315

    Article  CAS  Google Scholar 

  10. Gold PW, Pigott TA, Kling MA, Kalogeras K, Chrousos GP . Basic and clinical studies with corticotropin-releasing hormone. Implications for a possible role in panic disorder Psychiatr Clin North Am 1988; 11: 327–334

    Article  CAS  Google Scholar 

  11. Bornstein SR, Webster EL, Tropy DJ, Richman SJ, Mitsiades N, Igel M et al. Chronic effects of a nonpeptide corticotropin-releasing hormone type 1 receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation Endocrinology 1998; 139: 1546–1555

    Article  CAS  Google Scholar 

  12. Wong ML, Webster EL, Spokes H, Phu P, Ehrhart-Bornstein M, Bornstein SR et al. Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress Life Sci 1999; 65: PL53–58

    Article  CAS  Google Scholar 

  13. Deak T, Nguyen KT, Ehrlich AL, Watkins LR, Spencer RL, Maier SF et al. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress Endocrinology 1999; 140: 79–86

    Article  CAS  Google Scholar 

  14. Willenberg HS, Stratakis CA, Marx C, Ehrhart-Bornstein M, Chrousos GP, Bornstein SR . Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing's syndrome N Engl J Med 1998; 339: 27–31

    Article  CAS  Google Scholar 

  15. Haidan A, Bornstein SR, Glasow A, Uhlmann K, Lubke C, Ehrhart-Bornstein M . Basal steroidogenic activity of adrenocortical cells is increased 10-fold by coculture with chromaffin cells Endocrinology 1998; 139: 772–780

    Article  CAS  Google Scholar 

  16. Webster EL, Lewis DB, Torpy DJ, Zachman EK, Rice KC, Chrousos GP . In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation Endocrinology 1996; 137: 5747–5750

    Article  CAS  Google Scholar 

  17. Nussdorfer, Mazzocchi G . Immune-endocrine interactions in the mammalian adrenal gland: facts and hypotheses Int Rev Cytol 1998; 183: 143–184

    Article  CAS  Google Scholar 

  18. Suda T, Tomori N, Tozawa F, Mouri T, Demura H, Shizume K . Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues J Clin Endocrinol Metab 1984; 59: 861–866

    Article  CAS  Google Scholar 

  19. Suda T, Tomori N, Tozawa F, Demura H, Shizume K, Mouri T et al. Immunoreactive corticotropin and corticotropin-releasing factor in human hypothalamus, adrenal, lung cancer, and pheochromocytoma J Clin Endocrinol Metab 1984; 58: 919–924

    Article  CAS  Google Scholar 

  20. Bruhn TO, Engeland WC, Anthony ELP, Gann DS, Jackson IMD . Corticotropin-releasing factor in the dog adrenal medulla is secreted in response to hemorrhage Endocrinology 1987; 120: 25–33

    Article  CAS  Google Scholar 

  21. Edwards AV, Jones CT . Secretion of corticotropin releasing factor from the adrenal during splanchnic nerve stimulation in conscious calves J Physiol 1988; 400: 89–100

    Article  CAS  Google Scholar 

  22. McDonald TJ, Nathanielsz PW . The involvement of innervation in the regulation of fetal adrenal steroidogenesis Horm Metab Res 1998; 30: 297–302

    Article  CAS  Google Scholar 

  23. Venihaki M, Gravanis A, Margioris AN . Comparative study between normal rat chromaffin and PC12 rat pheochromocytoma cells: production and effects of corticotropin-releasing hormone Endocrinology 1997; 138: 698–704

    Article  CAS  Google Scholar 

  24. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP . Intraadrenal interactions in the regulation of adrenocortical steroidogenesis Endocr Rev 1998; 19: 101–143

    Article  CAS  Google Scholar 

  25. Pignatelli D, Magalhães MM, Magalhães MC . Direct effects of stress on adrenocortical function Horm Metab Res 1998; 30: 464–474

    Article  CAS  Google Scholar 

  26. Bagdy G, Calogero AE, Szemeredi K, Chrousos GP, Gold PW . Effects of cortisol treatment on brain and adrenal corticotropin-releasing hormone (CRH) content and other parameters regulated by CRH Regul Pept 1990; 31: 83–92

    Article  CAS  Google Scholar 

  27. Mazzocchi G, Malendowicz LK, Markowska A, Nussdorfer GG . Effect of hypophysectomy on corticotropin-releasing hormone and adrenocorticotropin immunoreactivities in the rat adrenal gland Mol Cell Neurosci 1994; 5: 345–349

    Article  CAS  Google Scholar 

  28. Bornstein SR, Vaudry H . Paracrine and neuroendocrine regulation of the adrenal gland—basic and clinical aspects Horm Metab Res 1998; 30: 292–296

    Article  CAS  Google Scholar 

  29. Grigoriadis DE, Lovenberg TW, Chalmers D, Liaw C, DeSouza EB . Characterization of corticotropin-releasing factor receptor subtypes Ann NY Acad Sci 1996; 780: 60–80

    Article  CAS  Google Scholar 

  30. Stenzel P, Kesterson R, Yeung W, Cone RD, Rittenberg MB, Stenzel-Poore MP . Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart Mol Endocrinol 1995; 9: 637–645

    CAS  PubMed  Google Scholar 

  31. Kishimoto T, Pearse RV, Lin CR, Rosenfeld MG . A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle Proc Natl Acad Sci USA 1995; 92: 1108–1112

    Article  CAS  Google Scholar 

  32. Chen R, Lewis KA, Perrin MH, Vale WW . Expression cloning of a human corticotropin-releasing factor receptor Proc Natl Acad Sci USA 1993; 90: 8967–8971

    Article  CAS  Google Scholar 

  33. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, DeSouza EB et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain Proc Natl Acad Sci USA 1995; 92: 836–840

    Article  CAS  Google Scholar 

  34. Chang CP, Pearse RV, O'Connell S, Rosenfeld MG . Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain Neuron 1993; 133: 3058–3061

    Google Scholar 

  35. Perrin MH, Donaldson CJ, Chen R, Lewis KA, Vale WW . Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor Endocrinology 1993; 133: 3058–3061

    Article  CAS  Google Scholar 

  36. Bornstein SR, Gonzalez-Hernandez JA, Ehrhart-Bornstein M, Adler G, Scherbaum WA . Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions J Clin Endocrinol Metab 1994; 78: 225–232

    CAS  PubMed  Google Scholar 

  37. Marx C, Ehrhart-Bornstein M, Scherbaum WA, Bornstein SR . Regulation of adrenocortical function by cytokines—relevance for immune-endocrine interaction Horm Metab Res 1998; 30: 416–420

    Article  CAS  Google Scholar 

  38. Path G, Bornstein SR, Ehrhart-Bornstein M, Scherbaum WA . Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: expression and effects on steroidogenesis J Clin Endocrinol Metab 1997; 82: 2343–2349

    CAS  Google Scholar 

  39. Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP . Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo Science 1991; 254: 421–423

    Article  CAS  Google Scholar 

  40. Webster EL, Torpy DJ, Elenkov IJ, Chrousos GP . Corticotropin-releasing hormone and inflammation Ann N Y Acad Sci 1998; 840: 21–32

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Keith Zachman, KC Rice and Jennifer Neria for their technical support. This work was supported by Heisenberg grant BO 1141 6-1 (to SRB).

Author information

Authors and Affiliations

  1. Diabetes Research Institute at the University of Düsseldorf, Germany

    H S Willenberg, G Päth & W A Scherbaum

  2. National Institute of Child Health and Human Development, NIH, Bethesda, MD, USA

    S R Bornstein, N Hiroi & G P Chrousos

  3. Department of Surgery at the University of Düsseldorf, Germany

    P E Goretzki

Authors
  1. H S Willenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S R Bornstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N Hiroi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G Päth
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P E Goretzki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W A Scherbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G P Chrousos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S R Bornstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Willenberg, H., Bornstein, S., Hiroi, N. et al. Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function. Mol Psychiatry 5, 137–141 (2000). https://doi.org/10.1038/sj.mp.4000720

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4000720

Keywords

This article is cited by

Search

Advanced search

Quick links